Stockholders’ Equity (Details)							3 Months Ended		6 Months Ended
	Jul. 10, 2023 shares	Jul. 05, 2023 $ / shares shares	May 23, 2023 shares	Jun. 16, 2022 USD ($) shares	May 30, 2022 $ / shares shares	Apr. 06, 2022 USD ($) $ / shares shares	Jun. 30, 2023 USD ($) $ / shares shares	Jun. 30, 2022 shares	Jun. 30, 2023 USD ($) $ / shares shares	Jun. 30, 2022 USD ($) shares	Dec. 31, 2022 $ / shares shares	Apr. 08, 2022 USD ($)
Class of Stock [Line Items]
Stock issuance costs | $									$ 0	$ 106,000
Preferred shares, shares authorized (in shares)							2,000,000		2,000,000		2,000,000
Preferred shares, par value (in dollars per share) | $ / shares							$ 0.0001		$ 0.0001		$ 0.0001
Preferred shares, shares issued (in shares)							15,000		15,000		15,000
Preferred shares, shares outstanding (in shares)							15,000		15,000		15,000
Common shares, shares authorized (in shares)							170,000,000		170,000,000		170,000,000
Common shares, par value (in dollars per share) | $ / shares							$ 0.0001		$ 0.0001		$ 0.0001
Common shares, shares outstanding (in shares)							16,795,673	9,407,296	16,795,673	9,407,296	12,163,673
Common shares, shares issued (in shares)							16,795,673		16,795,673		12,163,673
Exercise of Employee Stock Options, Net of Tax (in shares)							0	0	0	0
2018 Long Term Incentive Plan
Class of Stock [Line Items]
Additional common stock issuable (in shares)			1,600,000
Subsequent event
Class of Stock [Line Items]
Common shares, shares outstanding (in shares)	28,489,663
PIPE Purchase Agreement Pre-Funded Warrant
Class of Stock [Line Items]
Warrants exercised (in shares)							4,118,000	0	4,507,000	0
Number of shares of common stock for which warrant is exercisable (in shares)					1,267,897
Discount from stock price (dollars per share) | $ / shares					$ 0.0001
Exercise price of warrant (in dollars per share) | $ / shares					$ 0.0001
PIPE Purchase Agreement Pre-Funded Warrant | Subsequent event
Class of Stock [Line Items]
Warrants exercised (in shares)		1,793,000
Exercise price of warrant (in dollars per share) | $ / shares		$ 0.0001
Registered Direct Offering Warrants
Class of Stock [Line Items]
Number of shares of common stock for which warrant is exercisable (in shares)					7,788,480
Discount from stock price (dollars per share) | $ / shares					$ 0.0001
Exercise price of warrant (in dollars per share) | $ / shares					$ 0.0001
Ownership threshold					9.99%
Warrants outstanding (in shares)							1,793,000	9,056,377	1,793,000	9,056,377
PIPE Purchase Agreement Warrant
Class of Stock [Line Items]
Number of shares of common stock for which warrant is exercisable (in shares)					9,900,990
Exercise price of warrant (in dollars per share) | $ / shares					$ 1.39
Warrants outstanding (in shares)							9,900,990		9,900,990
Warrant price (dollars per share) | $ / shares					$ 0.125
PIPE Purchase Agreement Warrant | Subsequent event
Class of Stock [Line Items]
Warrants exercised (in shares)	9,900,990
Registered Direct Offering
Class of Stock [Line Items]
Number of shares issued					844,613
Common stock trading price (in dollars per share) | $ / shares					$ 1.39
Series X Convertible Preferred Stock
Class of Stock [Line Items]
Interest rate percentage						1.00%
Common stock trading price (per share) | $ / shares						$ 22.00
Accreted amount | $							$ 150,000		$ 150,000
Common stock trading period						30 days
Conversion price (per share) | $ / shares						$ 11.00
Convertible preferred stock (in shares)						91
Outstanding common stock, percentage						9.90%
Outstanding common stock, not to exceed, percentage						19.90%
Percentage of investment owned						50.00%
Maximum working capital line | $						$ 5,000,000
Consideration received | $						15,000,000
Stock issuance costs | $						100,000
Proceeds from sale of equity, net | $						14,900,000
Da Vita Healthcare Partners Inc | Share Issuance, Tranche One
Class of Stock [Line Items]
Proceeds from issuance of convertible preferred stock | $				$ 7,500,000		7,500,000
Da Vita Healthcare Partners Inc | Series X Convertible Preferred Stock | Private Placement
Class of Stock [Line Items]
Sale of stock, aggregate consideration authorized | $						$ 15,000,000
Common stock trading price (in dollars per share) | $ / shares						$ 1,000
Da Vita Healthcare Partners Inc | Series X Convertible Preferred Stock | Private Placement | Share Issuance, Tranche One
Class of Stock [Line Items]
Number of shares issued				7,500		7,500
Cantor Fitzgerald & Co | Controlled Equity Offering
Class of Stock [Line Items]
Sale of stock, aggregate consideration authorized | $												$ 12,200,000